Vanguard Group Inc Cytosorbents Corp Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,949,551 shares of CTSO stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,949,551
Previous 1,949,551
-0.0%
Holding current value
$1.79 Million
Previous $1.75 Million
11.12%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CTSO
# of Institutions
56Shares Held
16.8MCall Options Held
8.1KPut Options Held
6.9K-
Avenir Corp Washington, DC5.04MShares$4.64 Million0.55% of portfolio
-
Skylands Capital, LLC2.62MShares$2.41 Million0.55% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.55 Million0.0% of portfolio
-
Cm Management, LLC954KShares$877,7491.04% of portfolio
-
Sargent Investment Group, LLC824KShares$757,6200.13% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $40.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...